Abstract:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is adapting to continuous presence in humans. Transitions to endemic infection patterns are associated with changes in the spike (S) proteins that direct virus-cell entry. These changes generate antigenic drift and thereby allow virus maintenance in the face of prevalent human antiviral antibodies. These changes also fine tune virus-cell entry dynamics in ways that optimize transmission and infection into human cells. Focusing on the latter aspect, we evaluated the effects of several S protein substitutions on virus-cell membrane fusion, an essential final step in enveloped virus-cell entry. Membrane fusion is executed by integral-membrane "S2" domains, yet we found that substitutions in peripheral "S1" domains altered late-stage fusion dynamics, consistent with S1-S2 heterodimers cooperating throughout cell entry. A specific H655Y change in S1 stabilized a fusion-intermediate S protein conformation and thereby delayed membrane fusion. The H655Y change also sensitized viruses to neutralization by S2-targeting fusion-inhibitory peptides and stem-helix antibodies. The antibodies did not interfere with early fusion-activating steps; rather they targeted the latest stages of S2-directed membrane fusion in a novel neutralization mechanism. These findings demonstrate that single amino acid substitutions in the S proteins both reset viral entry—fusion kinetics and increase sensitivity to antibody neutralization. The results exemplify how selective forces driving SARS-CoV-2 fitness and antibody evasion operate together to shape SARS-CoV-2 evolution. Most adaptive mutations endowing SARS-CoV-2 with increased human transmissibility and infectivity alter viral spike (S) protein structure and function. Orchestrated structural transitions in these multidomain S proteins mediate cell entry functions. Comparative analyses of adapted SARS-CoV-2 variants identified S domains conducting the rhythm of these transitions. The S1 adaptation H655Y slowed late virus-cell membrane fusion, revealing S1 as a timer for this essential and final cell entry event. The H655Y-directed delay left viruses vulnerable to neutralizing antibodies that target transitional fusion intermediate S conformations. Our findings highlight how mechanistic understandings of S protein structural dynamics illuminate antibody neutralization mechanisms and suggest that SARS-CoV-2 evolutionary pathways are shaped by competing selective pressures to optimize cell entry kinetics and evade neutralizing antibodies.

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant

SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion

Unraveling the binding mechanisms of SARS-CoV-2 variants through molecular simulations

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex

Comprehensive Analysis of SARS-CoV-2 Spike Evolution: Epitope Classification and Immune Escape Prediction

SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization

Evolution of enhanced innate immune evasion by SARS-CoV-2

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape

Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain

Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry

AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance

Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages

Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion

Emerging severe acute respiratory syndrome coronavirus 2 variants and their impact on immune evasion and vaccine-induced immunity

Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations

Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

SARS-CoV-2 Delta and Omicron Variants Evade Population Antibody Response by Mutations in a Single Spike Epitope.